iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Glenmark Pharmaceuticals Ltd Option Chain

1,541.45
(0.37%)
Dec 26, 2024|03:31:25 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Ol (lots)Call PriceStrike PricePut PriceOl (lots)
7250%₹562.050%1,140--
7,975-8.33%₹499.15-1.86%1,200₹0.05-80%66,700-2.12%
--1,220₹0.350%10,1500%
--1,240₹0.05-91.66%10,1500%
--1,260₹0.10%19,5750%
2,9000%₹1700%1,280₹0.40%4,3500%
15,9500%₹399.45-2.13%1,300₹0.05-66.66%68,1500%
2,1750%₹160.90%1,320₹0.1550%29,725-4.65%
2,900300%₹363-0.81%1,340₹0.05-66.66%52,925-2.66%
7,9750%₹149.10%1,360₹0.05-50%81,9250%
7250%₹134.750%1,380₹0.150%28,2750%
42,050-19.44%₹293-5.08%1,400₹0.10%1,40,650-19.16%
27,550-11.62%₹276-3.15%1,420₹0.05-66.66%39,150-10%
53,650-23.71%₹260-2.8%1,440₹0.050%1,05,125-7.64%
76,125-5.40%₹235-2.08%1,460₹0.10%76,125-22.22%
55,825-4.93%₹218.65-4.51%1,480₹0.150%75,400-8.77%
1,02,950-30.39%₹225.359.92%1,500₹0.05-66.66%2,97,250-12.39%
89,175-4.65%₹181.551.99%1,520₹0.05-50%1,15,275-12.15%
1,39,925-7.21%₹153.95-8.33%1,540₹0.05-50%72,500-35.89%
90,625-13.19%₹136-8.1%1,560₹0.05-50%1,45,725-2.89%
69,600-23.80%₹114.6-4.46%1,580₹0.150%1,15,275-3.63%
1,95,025-24.43%₹85.5-20.61%1,600₹0.05-75%2,34,900-26.36%
73,950-11.30%₹75-12.94%1,620₹0.05-50%2,34,900-3.28%
92,075-16.99%₹62-6.34%1,640₹0.05-87.5%1,48,625-19.29%
74,675-14.16%₹34-27.96%1,660₹0.05-91.66%1,87,050-29.12%
62,350-58.04%₹15.65-44.99%1,680₹0.05-94.11%1,13,825-54.62%
1,16,000-65.06%₹0.05-99.5%1,700₹11.7397.87%1,26,150-69.20%
1,32,675-22.78%₹0.05-97.72%1,720₹30106.18%52,200-14.28%
56,550-49.35%₹0.05-94.11%1,740₹300%1,4500%
38,425-49.03%₹0.05-91.66%1,760--
22,475-13.88%₹0.05-87.5%1,780--
17,400-48.93%₹0.05-75%1,800--
12,325-29.16%₹0.050%1,840--
7250%₹0.750%1,880--

Glenmark Pharma.: Related NEWS

Glenmark Launches Generic Glaucoma Drug
27 Nov 2024|12:23 PM

According to a statement from the firm, the Travoprost ophthalmic solution (0.004% ionic buffered solution) is both bioequivalent and therapeutically equivalent to the reference listed medication

Read More
Glenmark Pharmaceuticals Posts ₹354.4 Crore Profit in Q2
18 Nov 2024|10:45 AM

The company also reported revenue from operations to ₹3433.7 Crore. The EBITDA margin for the quarter that ended on September 30, 2024 stands at 17.5%.

Read More
Glenmark Recalls US Products Over Manufacturing Issues
14 Oct 2024|01:22 PM

Glenmark Pharmaceuticals Inc, USA, issued a countrywide (US) Class II recall on September 24 this year.

Read More
Glenmark Pharmaceuticals' Aurangabad Facility Passes FDA Inspection
23 Sep 2024|01:08 PM

This positive outcome indicates compliance with FDA standards and enhances Glenmark's credibility in the pharmaceutical sector.

Read More
Glenmark Shares Surge on Positive FDA Inspection
23 Sep 2024|12:55 PM

In conclusion, the US Food and Drug Administration (USFDA) has issued Form 483 with no observations.

Read More
Top 10 stocks for today – 23rd September 2024
23 Sep 2024|09:34 AM

Here are some of the stocks that may see significant price movement today: HFCL, Aster DM Healthcare, Tata Steel, Glenmark Pharma, etc.

Read More
Glenmark Launches Allergy Eye Drops in US, Shares Surge 4%
19 Aug 2024|12:53 PM

Revenue from operations grew by 6.9%, reaching ₹3,244.2 Crore compared to ₹3,036 Crore in the same quarter of the previous fiscal year.

Read More
Top 10 stocks for today – 18th July 2024
18 Jul 2024|09:07 AM

Here are some of the stocks that may see significant price movement today: Asian Paints, LTIMindtree, L&T Finance, Zee Entertainment, etc.

Read More
Glenmark Pharmaceuticals divests stake in Glenmark Life after Nirma Acquisition
11 Jul 2024|01:16 PM

The sale will be conducted through the stock exchange mechanism, adhering to applicable legal requirements.

Read More
Top 10 stocks for today – 11th July 2024
11 Jul 2024|08:38 AM

Here are some of the stocks that may see significant price movement today: SBI, Sula Vineyards, Zydus Lifesciences, Kesoram Industries, etc.

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2024, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp